1. Sputnik V Covid-19 vaccine made by Russia gets nod for clinical trials in India  Zee News
  2. Dr Reddy’s gets DCGI nod to conduct clinical trial for Sputnik V vaccine in India  Mint
  3. Vaccines against Covid-19 may not need to be administered annually: WHO Official  Hindustan Times
  4. COVID-19 Vaccine Latest Updates: What's Happening in India, China, US, and Russia  India.com
  5. Chinese COVID-19 vaccine candidate shows promise in human trial: Study  Moneycontrol
  6. View Full coverage on Google News
The Drug Controller General of India (DCGI) has granted approval to Dr Reddy`s, a global pharmaceutical company headquartered in India, to conduct phase 2 and 3 clinical human trials of the Sputnik V, a Covid-19 vaccine made by Russia.The Drug Controller General of India (DCGI) has granted approval to Dr Reddy`s, a global pharmaceutical company headquartered in India, to conduct phase 2 and 3 clinical human trials of the Sputnik V, a Covid-19 vaccine made by Russia.

Sputnik V Covid-19 vaccine made by Russia gets nod for clinical trials in India | India News | Zee News

Serum Institute of India can produce 700-800 million vaccine dosages every year once things are streamlined, executive director of SII said.The vaccine is likely to provide protection for about a year, AstraZeneca CEO Pascal Soriot saidSerum Institute of India can produce 700-800 million vaccine dosages every year once things are streamlined, executive director of SII said.The vaccine is likely to provide protection for about a year, AstraZeneca CEO Pascal Soriot said

COVID-19 vaccine may be ready by December, to be available in market by March: SII official

India News: As the world prepares for a vaccine against Covid-19, India has started identifying around 30 crore priority beneficiaries, including high-risk populIndia News: As the world prepares for a vaccine against Covid-19, India has started identifying around 30 crore priority beneficiaries, including high-risk popul

Covid-19: Govt identifying 30 crore who will get vaccine on priority | India News - Times of India

The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian COVID-19 vaccine, the sovereign wealth fund said on Saturday.The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian COVID-19 vaccine, the sovereign wealth fund said on Saturday.

COVID-19 Vaccine: Russia Receives Renewed Approval For COVID-19 Vaccine Trials In India

Russia is approving vaccines after small-scale trials, which is a cause for concern over Sputnik V’s safety. This is why Dr Reddy’s was not given permission to test it among a comparatively larger population in India.Russia is approving vaccines after small-scale trials, which is a cause for concern over Sputnik V’s safety. This is why Dr Reddy’s was not given permission to test it among a comparatively larger population in India.

Covid-19 vaccine: Sputnik V to undergo trial in India, Dr Reddy’s gets DCGI approval - india news - Hindustan Times

Coronavirus vaccine update: US pharma giant Pfizer, which is developing a potential coronavirus vaccine with BioNTech, has said it could have the vaccine in November. Pfizer Inc has announced that it could apply for US authorisation of the vaccine by November.Coronavirus vaccine update: US pharma giant Pfizer, which is developing a potential coronavirus vaccine with BioNTech, has said it could have the vaccine in November. Pfizer Inc has announced that it could apply for US authorisation of the vaccine by November.

Coronavirus vaccine update: Trials of Sputnik V likely to resume in India, Pfizer says US could have vaccine by November - Coronavirus Outbreak News

These two pharma heavyweights are among the many players racing to get a COVID-19 vaccine approved.These two pharma heavyweights are among the many players racing to get a COVID-19 vaccine approved.

Better Coronavirus Stock: AstraZeneca or Johnson & Johnson | The Motley Fool

Bloomberg - Are you a robot?

Other headlines: Dr Reddy’s got permission to conduct trials of Russia’s coronavirus vaccine, and a court ordered an FIR against Kangana Ranaut and her sister.Other headlines: Dr Reddy’s got permission to conduct trials of Russia’s coronavirus vaccine, and a court ordered an FIR against Kangana Ranaut and her sister.

India news: Narendra Modi says access to coronavirus vaccine should be ensured speedily

Other headlines: Dr Reddy’s got permission to conduct trials of Russia’s coronavirus vaccine, and a court ordered an FIR against Kangana Ranaut and her sister.Other headlines: Dr Reddy’s got permission to conduct trials of Russia’s coronavirus vaccine, and a court ordered an FIR against Kangana Ranaut and her sister.

India news: Narendra Modi says access to coronavirus vaccine should be ensured speedily

Russia’s sovereign wealth fund and Dr Reddy’s had agreed to collaborate on clinical trials and distribution of the vaccine in September.Russia’s sovereign wealth fund and Dr Reddy’s had agreed to collaborate on clinical trials and distribution of the vaccine in September.

Coronavirus: Dr Reddy’s gets drugs regulator approval to test Russia’s Sputnik-V vaccine

New Delhi: Having refused permission earlier, the Drugs Controller General of India (DCGI) has now allowed Dr Reddy’s to conduct phase 2/3 clinical human trials of Russia’s Sputnik V vaccine candidate.“This will be a multi-centre and randomized contr

COVID-19 Vaccine: Sputnik V Finally Gets DCGI Nod For Phase 2/3 Trials In India – ODISHA BYTES

The Times of India said that frontline health and sanitation workers, police officials and elderly people with co-morbidities will get the vaccine on priority.The Times of India said that frontline health and sanitation workers, police officials and elderly people with co-morbidities will get the vaccine on priority.

Government begins selecting people for priority coronavirus vaccines

India is identifying 300 million people who will receive the initial dose of a coronavirus vaccine, the Times of India newspaper reported on Saturday. Priority will be given to workers in high-risk sectors such as police, health-care, sanitation, elderly people and those with co-morbidities, the report said, citing officials it didn’t identify. The shots, which will include aIndia is identifying 300 million people who will receive the initial dose of a coronavirus vaccine, the Times of India newspaper reported on Saturday. Priority will be given to workers in high-risk

Govt identifying 30 crore people who'll get Covid-19 vaccine on priority: Report | Deccan Herald

Currently, Sputnik V vaccine is undergoing post-registration clinical trials on 40,000 volunteers in RussiaCurrently, Sputnik V vaccine is undergoing post-registration clinical trials on 40,000 volunteers in Russia

RDIF and Dr. Reddy's receives approval for Sputnik V clinical trials in India - Russia - TASS

RDIF and Dr. Reddy's receives approval for Sputnik V clinical trials in India

Sputnik V, an adenovirus vector-based vaccine, was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, along with the Russian Direct Investment Fund.Sputnik V, an adenovirus vector-based vaccine, was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, along with the Russian Direct Investment Fund.

Dr Reddy's Gets DCGI Nod To Conduct Stage 2/3 Human Trials For Russia's Sputnik V Covid-19 Vaccine

India’s vaccines regulator has given the green light for a clinical study of the Russia-developed Covid-19 vaccine. Similar trials of the formulation are underway in Russia itself and in some other nations.India’s vaccines regulator has given the green light for a clinical study of the Russia-developed Covid-19 vaccine. Similar trials of the formulation are underway in Russia itself and in some other nations.

India gives go-ahead to domestic trial of Russia’s pioneering ‘Sputnik V’ Covid-19 vaccine — RT Russia & Former Soviet Union

Sputnik V Covid-19 vaccine gets nod for clinical trials in India, Latest news in India, Top breaking headlines on politics, current affairs, news live from other states on business, technology - Mathrubhumi, Latest India News | India Breaking News | India Politics | Mathrubhumi English, Latest India News | India Breaking News | India Politics | Mathrubhumi EnglishNew Delhi: The Drug Controller General of India (DCGI) has granted approval to Dr ..

Sputnik V Covid-19 vaccine gets nod for clinical trials in India | Sputnik V Covid-19 vaccine trial

The spokesman stressed that it is incorrect to speak about competition proper in the coronavirus vaccine development fieldThe spokesman stressed that it is incorrect to speak about competition proper in the coronavirus vaccine development field

Russia proud of its COVID-19 vaccine not smearing foreign ones — Kremlin - Russian Politics & Diplomacy - TASS

Russia proud of its COVID-19 vaccine not smearing foreign ones — Kremlin

India is in the process of finalising a top priority list of nearly 30 crore people, including health workers, police personnel, sanitation workers, the elderly and people with co-morbidities for getting an estimated 60 crore Covid-19 vaccine shots. "The first list is expected to be ready by this month-end or early November," a Health Ministry official said. The initial phaseIndia is in the process of finalising a top priority list of nearly 30 crore people, including health workers, police personnel, sanitation workers, the elderly and people with co-morbidities for

India finalising list of 30 crore for Covid-19 vaccine | The Daily Star

Currently, scientists, health researchers and drugmakers all over the world are racing to produce a safe and effective vaccine against coronavirus.Currently, scientists, health researchers and drugmakers all over the world are racing to produce a safe and effective vaccine against coronavirus.

Nation’s broken health-care system cannot cope with strain of prolonged pandemicNation’s broken health-care system cannot cope with strain of prolonged pandemic

Report: India selecting 300m people for COVID-19 vaccine | India – Gulf News

EXCLUSIVE: Britain will be behind in the queue as Trump, who put $1bn into AstraZeneca to develop the drug, orders his defence and health chiefs to ensure that the US has the jab first EXCLUSIVE: Britain will be behind in the queue as Trump, who put $1bn into AstraZeneca to develop the drug, orders his defence and health chiefs to ensure that the US has the jab first

Donald Trump may buy up Britain's coronavirus vaccine before UK gets any - Mirror Online

On August 11, Sputnik V became the world’s first registered vaccine against Covid-19On August 11, Sputnik V became the world’s first registered vaccine against Covid-19

Russian Covid-19 vaccine Sputnik V gets nod for clinical trial in India | Dhaka Tribune

Priority will be given to workers in high-risk sectors such as police, healthcare and sanitation.. Read more at straitstimes.com.South Asia News -Priority will be given to workers in high-risk sectors such as police, healthcare and sanitation.. Read more at straitstimes.com.

India selecting 300 million people for Covid-19 vaccine: Media, South Asia News & Top Stories - The Straits Times

THE Foreign Secretary has slammed Russian 'fake news factory' claims that the Oxford University Covid-19 vaccine will turn people into monkeys.THE Foreign Secretary has slammed Russian "fake news factory" claims that the Oxford University Covid-19 vaccine will turn people into monkeys.

Dominic Raab blasts Russia as 'fake news factory' after vaccine monkey claim | UK | News | Express.co.uk

The head of Russia’s sovereign wealth fund has said he will reconsider referring to the Oxford vaccine as “the monkey vaccine” after a Times investigation uncovered a disinformation campaign againstThe head of Russia’s sovereign wealth fund has said he will reconsider referring to the Oxford vaccine as “the monkey vaccine” after a Times investigation uncovered a disinformation campaign against

Disinformation created in Russia has flooded social media to discredit the vaccine set to be distributed by pharma giant Astrazeneca, claiming it uses a chimpanzee virus as a vector.Russia is going bananas in its efforts to undermine a coronavirus vaccine being developed by Britain’s Oxford University — claiming it could turn people into monkeys, according to a

Russia disinformation says UK COVID vaccine turns people into monkeys

A Russian smear campaign has claimed that the trial COVID-19 vaccine being developed at Oxford will turn people into monkeys.A Russian smear campaign has claimed that the trial COVID-19 vaccine being developed at Oxford will turn people into monkeys.

Russian Smear Campaign Launched Against Oxford Vaccine

A Russian smear campaign has claimed that the trial COVID-19 vaccine being developed at Oxford will turn people into monkeys.A Russian smear campaign has claimed that the trial COVID-19 vaccine being developed at Oxford will turn people into monkeys.

Russian Smear Campaign Launched Against Oxford Vaccine

Fake memes spread online depict recipients turning into chimpanzeesFake memes spread online depict recipients turning into chimpanzees

‘Deplorable’: UK government condemns alleged Russian disinformation about Oxford coronavirus vaccine | The Independent

The country has been accused of targeting Western websites with misinformation in a smear campaign, it comes amid reports the country aims to launch its own Sputnik V jab The country has been accused of targeting Western websites with misinformation in a smear campaign, it comes amid reports the country aims to launch its own Sputnik V jab

Russia 'spreads conspiracy theory' that Covid vaccine 'turns you into monkey' - Daily Star

Children's lives could be put in danger by disinformation campaigns about vaccines, a leading expert warned today. Andrew Pollard, Professor of Paediatric Infection and Immunity at Oxford University, issued the warning amid claims that a Russian disinformation campaign is seeking to spread fear about a Covid-19 vaccine being developed by Oxford University and pharmaceuticalChildren's lives could be put in danger by disinformation campaigns about vaccines, a leading expert warned today. Andrew Pollard, Professor of Paediatric Infection and Immunity at Oxford University,

Vaccine scare stories ‘put children’s lives at risk’ | London Evening Standard

When Ronald Reagan told an audience of American evangelicals in 1983 that the Soviet Union was an “evil empire”, he [...When Ronald Reagan told an audience of American evangelicals in 1983 that the Soviet Union was an “evil empire”, he [...

Disinformation aimed at Oxford’s vaccine is the work of a new evil empire | TheArticle

Earlier on Friday, British Foreign Secretary Dominic Raab warned that attempts "to basically sabotage the efforts of those trying to develop a vaccine are deeply...Earlier on Friday, British Foreign Secretary Dominic Raab warned that attempts "to basically sabotage the efforts of those trying to develop a vaccine are deeply...

Moscow Denies Accusations of Spreading Misinformation About UK's COVID-19 Vaccine - Sputnik International

Russia is spreading fake news regarding the effects of Oxford's Coronavirus vaccine, claiming that it will turn humans into monkeysRussia is spreading fake news regarding the effects of Oxford's Coronavirus vaccine, claiming that it will turn humans into monkeys

'Don't Worry, Monkey Vaccine Is Fine': UK Minister Blasts Russia Over Spreading Fake News on Oxford Vaccine

HuffPost is now a part of Verizon Media

Foreign Secretary Dominic Raab has condemned a reported Russian disinformation campaign to undermine confidence in a British coronavirus vaccine as "utterly deplorable". Pictures,Foreign Secretary Dominic Raab has condemned a reported Russian disinformation campaign to undermine confidence in a British coronavirus vaccine as "utterly deplorable". Pictures,

Raab accuses Russia of ‘shabby’ disinformation over coronavirus vaccine - AOL

Russia is waging a disinformation attack on Oxford University and Astrazeneca's coronavirus vaccine, according to an investigation by British newspaper The Times. Russia's flagship Vesti News programme called it a "monkey vaccine". "Russia and middlemen a...Russia is waging a disinformation attack on Oxford University and Astrazeneca's coronavirus vaccine, according to an investigation by British newspaper The Times. Russia's flagship Vesti News programme called it a "monkey vaccine". "Russia and middlemen a...

Report: Russia trying to discredit Oxford vaccine

A RUSSIAN campaign has been launched to discredit the Oxford coronavirus vaccine, The Times reports.A RUSSIAN campaign has been launched to discredit the Oxford coronavirus vaccine, The Times reports.

Russia spreads fake news about Oxford coronavirus vaccine | Oxford Mail

The selected individuals will be given an estimated 600 million doses.The selected individuals will be given an estimated 600 million doses.

India begins selecting people for priority coronavirus vaccines - News | Khaleej Times

The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian COVID-19 vaccine, the sovereign wealth fund said on Saturday.The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian COVID-19 vaccine, the sovereign wealth fund said on Saturday.

Russia receives renewed approval for COVID-19 vaccine trials in India: RDIF | Reuters

India is identifying 300 million people who will receive the initial dose of a coronavirus vaccine, the Times of India newspaper reported on Saturday.Priority will be given to workers in high-risk sectors, elderly people and those with co-morbidities, Times of India reported.

Covid Vaccine: India Selecting 300 Million People for Covid Vaccine, Times Says